date:Jan 22, 2014
ical research programme, further complemented by our participation in the EU BACCHUS Project, constitutes one of the largest research endeavors in the polyphenols space.
Tom Dhoore, Area Manager of Ferrer HealthTech: Bioactors scientific excellence and intellectual property perfectly complements Ferrer HealthTechs expertise in polyphenols. Moreover, the agreement strengthens our value proposition to our customers in North and South America .
Hans van der Saag, Managing Director of Bioactor com